Alerts will be sent to your verified email
Verify EmailSAWABUSI
Sawaca Enterprises
|
Novelix Pharma
|
PALM Jewels
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
2.87 % | -17.5 % | 1.29 % |
5yr average Equity Multiplier
|
1.12 | 1.26 | 1.2 |
5yr Average Asset Turnover Ratio
|
0.22 | 0.84 | 4.42 |
5yr Avg Net Profit Margin
|
15.19 % | -14.11 % | 0.22 % |
Price to Book
|
0.5 | 4.03 | 1.87 |
P/E
|
0.0 | 351.61 | 53.4 |
5yr Avg Cash Conversion Cycle
|
-16.32 Days | 29.1 Days | 58.07 Days |
Inventory Days
|
62.4 Days | 34.04 Days | 72.32 Days |
Days Receivable
|
33.59 Days | 55.38 Days | 1.54 Days |
Days Payable
|
218.53 Days | 55.7 Days | 4.09 Days |
5yr Average Interest Coverage Ratio
|
66.03 | -17.77 | 3.18 |
5yr Avg ROCE
|
3.76 % | -15.4 % | 2.36 % |
5yr Avg Operating Profit Margin
|
-28.4 % | -16.49 % | 0.45 % |
5 yr average Debt to Equity
|
0.02 | 0.05 | 0.14 |
5yr CAGR Net Profit
|
18.13 % | 35.78 % | 27.23 % |
5yr Average Return on Assets
|
2.54 % | -13.36 % | 1.06 % |
Shareholdings
|
|||
Promoter Holding
|
0.82 % | 66.56 % | 43.36 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-22.65 % | -0.36 % | -10.22 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Sawaca Enterprises
|
Novelix Pharma
|
PALM Jewels
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|